中文名 | YK-4-279 |
英文名 | YK-4-279 |
别名 | YK-4-279游离态 RHA与EWS-FLI1结合抑制剂(YK-4-279) 4,7-二氯-3-羟基-3-(2(4-甲氧基苯基)-2-氧代乙基)二氢吲哚-2-酮 4,7-二氯-1,3-二氢-3-羟基-3-[2-(4-甲氧基苯基)-2-氧代乙基]-2H-吲哚-2-酮 |
英文别名 | CS-1785 YK 4-279 YK-4-279 4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one 4,7-Dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indol-2-one 2H-Indol-2-one, 4,7-dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]- 4,7-Dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indol-2-one YK-4-279 |
CAS | 1037184-44-3 |
化学式 | C17H13Cl2NO4 |
分子量 | 366.2 |
密度 | 1.456 |
熔点 | 149-151℃ |
沸点 | 608.9±55.0 °C(Predicted) |
酸度系数 | 10.43±0.20(Predicted) |
存储条件 | Store at -20° C. |
体外研究 | YK-4-279 eliminates cyclin D levels by blocking the interaction of EWS-FLI1 with RHA in EWS-FLI1-containing TC32 cells. YK-4-279 also specifically inhibits ESFT cell growth and induces apoptosis. YK-4-279 also inhibits ERG and ETV1 biological activity in fusion-positive prostate cancer cells, and further decreases cell motility and invasion. |
体内研究 | In vivo, YK-4-279 (1.5 mg/dose i.p.) inhibits the growth of ESFT xenograft tumors. In mouse model, YK-4-279 selectively prevents prostate cancer growth and metastasis in fusion-positive LNCaP-luc-M6 tumors. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.731 ml | 13.654 ml | 27.307 ml |
5 mM | 0.546 ml | 2.731 ml | 5.461 ml |
10 mM | 0.273 ml | 1.365 ml | 2.731 ml |
5 mM | 0.055 ml | 0.273 ml | 0.546 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!